Michel Vounatsos

Chief Executive Officer at Biogen, Inc.

Michel Vounatsos

Michel Vounatsos

Chief Executive Officer at Biogen, Inc.

Overview
Career Highlights

Biogen, Inc.
Biogen GmbH
Biogen Idec, Inc. (North Carolina)

RelSci Relationships

1253

Number of Boards

6

Birthday

1962

Age

58

Relationships
RelSci Relationships are individuals Michel Vounatsos likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chief Executive Officer at DPx Holdings BV

Relationship likelihood: Strong

Chief Medical Officer at Biogen, Inc.

Relationship likelihood: Strong

Executive Chairman at Rgenix, Inc.

Relationship likelihood: Strong

Executive Vice President & Chief Human Resources Officer at Biogen, Inc.

Relationship likelihood: Strong

Board of Trustees, Goldman Sachs at Intellia Therapeutics, Inc.

Relationship likelihood: Strong

Co-Founder at Ivy Capital Partners LLC

Relationship likelihood: Strong

Co-Founder at Exelixis, Inc.

Relationship likelihood: Strong

Founder at Point Rider Group LLC

Relationship likelihood: Strong

Founding Partner at Sarissa Capital Management LP

Relationship likelihood: Strong

Former Chief Executive Officer & President at Tufts Health Plan

Relationship likelihood: Strong

Paths to Michel Vounatsos
Potential Connections via
Relationship Science
You
Michel Vounatsos
Chief Executive Officer at Biogen, Inc.
Education
MBA

Founded in 1881 by the Paris Chamber of Commerce and Industry, HEC Paris specializes in education and research in management sciences. As a leading academic institution in Europe and worldwide, HEC Paris offers a complete and unique range of education programs for students and leaders. HEC Paris has a permanent faculty of 106 professors, 4,000 students and over 8,500 managers in executive education programs every year.

Career History
Chief Executive Officer & Director
2016 - ?

Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is an American company located in Durham, NC. The firm develops pharmaceutical products. Michel Vounatsos has been the CEO since 2016.

President-Primary Care Business Line
Prior - 2016

Merck & Co., Inc. , d.b.a. Merck Sharp & Dohme, MSD outside the United States and Canada, is an American pharmaceutical company and is one of the largest pharmaceutical companies in the world.

Chief Executive Officer & Member-Supervisory Board
Current

Biogen GmbH, part of Biogen, Inc., is a company headquartered in Ismaning, Germany. The firm discovers, develops, manufactures and supplies pharmaceutical products. It was founded in 1978 by Phillip Sharp, Walter Gilbert, Charles Weissman, Heinz Schaller and Kenneth Murray. Michel Vounatsos is the current CEO of the firm.The company says this about itself: Biogen GmbH is a German manufacturer of biochemical products for Medical Biology. Above all an independent German Company, Biogen GmbH is the signature of High Quality Performances. Biogen GmbH Reagents comply with all your Quality requirements.

Boards & Committees
Member, Board of Directors
2020 - Current

As a global technology leader, PerkinElmer is taking action to harness the power of insights and transform them into knowledge to deliver innovative, differentiated solutions for our customers. From critical therapeutic and disease research and prenatal screening, to environmental testing and industrial monitoring, we are actively engaged in improving health and advancing quality and longevity of life all around the world. From multi-vendor laboratory services, software and informatics, to clinical lab testing and unparalleled customer care, we have the people, tools and resources to help customers solve their business and scientific goals. Our core competencies, coupled with our commitment to excellence, provide a strong foundation for delivering optimal service and support. By encouraging exploration, ingenuity and integrity, together with teamwork and employee development, at PerkinElmer we live our mission, every day

Director & Chief Executive Officer
Current

Biogen has some of the world’s best neurologists and neuroscientists. They engage with physicians and scientific leaders around the world with the aim to further medical research. Their focus on neuroscience, their deep scientific expertise and courage to take risks makes them leaders in the research and development of medicines to transform neuroscience to benefit society. Their technology and engineering capabilities create novel ways to seamlessly transition products from development to manufacturing with the intent of bringing their high-quality medicines to market faster. They respect the contributions of health care providers caring for people living with neurological diseases. They honor the important role of caregivers, families and friends who care about them.

Chief Executive Officer & Member-Supervisory Board
Current

Biogen GmbH, part of Biogen, Inc., is a company headquartered in Ismaning, Germany. The firm discovers, develops, manufactures and supplies pharmaceutical products. It was founded in 1978 by Phillip Sharp, Walter Gilbert, Charles Weissman, Heinz Schaller and Kenneth Murray. Michel Vounatsos is the current CEO of the firm.The company says this about itself: Biogen GmbH is a German manufacturer of biochemical products for Medical Biology. Above all an independent German Company, Biogen GmbH is the signature of High Quality Performances. Biogen GmbH Reagents comply with all your Quality requirements.

Director
Current

Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC.

Vice President
Tenure Unconfirmed
Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Michel Vounatsos. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Michel Vounatsos's profile does not indicate a business or promotional relationship of any kind between RelSci and Michel Vounatsos.